Last reviewed · How we verify
Fibrinogen/thrombin-coated collagen patch — Competitive Intelligence Brief
marketed
Hemostatic agent / Surgical sealant
Surgery / Hemostasis
Small molecule
Live · refreshed every 30 min
Target snapshot
Fibrinogen/thrombin-coated collagen patch (Fibrinogen/thrombin-coated collagen patch) — Asan Medical Center. A collagen patch coated with fibrinogen and thrombin that promotes hemostasis by providing a scaffold for clot formation and delivering clotting factors directly to the wound site.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fibrinogen/thrombin-coated collagen patch TARGET | Fibrinogen/thrombin-coated collagen patch | Asan Medical Center | marketed | Hemostatic agent / Surgical sealant |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Hemostatic agent / Surgical sealant class)
- Asan Medical Center · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fibrinogen/thrombin-coated collagen patch CI watch — RSS
- Fibrinogen/thrombin-coated collagen patch CI watch — Atom
- Fibrinogen/thrombin-coated collagen patch CI watch — JSON
- Fibrinogen/thrombin-coated collagen patch alone — RSS
- Whole Hemostatic agent / Surgical sealant class — RSS
Cite this brief
Drug Landscape (2026). Fibrinogen/thrombin-coated collagen patch — Competitive Intelligence Brief. https://druglandscape.com/ci/fibrinogen-thrombin-coated-collagen-patch. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab